Riskpilot← Back to searchSign inGet full accessCELLVISION HOLDING AS
ASActiveOrg 914607221Tyrihansveien 14, 1388 BorgenKonsulentvirksomhet tilknyttet informasjonsteknologi · NACE 62020Est. 20140 employees
Revenue 2019
NOK 0
EBITDA margin
—
+40% vs 2018
Equity ratio
98.4%
Financial strength
Net profit 2019
NOK -43K
+56% vs 2018
| Revenue | NOK 0 | — |
| EBITDA | NOK -83K | +40% |
| Net profit | NOK -43K | +56% |
| Total assets | NOK 8,2M | -1% |
| Equity | NOK 8M | -1% |
| Employees | 0 | — |
Legal name
CELLVISION HOLDING AS
Org number
914607221
Legal form
Aksjeselskap
NACE code
62020 · Konsulentvirksomhet tilknyttet informasjonsteknologi
Founded
12. desember 2014
Share capital
NOK 44 844 960
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Investering i aksjer og andre verdipapirer, forvaltning av eierinteresser og annen virksomhet som står i forbindelse med dette.
Address
Tyrihansveien 14, 1388 Borgen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −584 | −248 | −68 | −34 |
| EBITDA | −6 | −43 | −1 623 | −332 | −139 | −83 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −6 | −43 | −1 623 | −332 | −139 | −83 |
| Net financials | 0 | 37 915 | 917 | 2 938 | 40 | 40 |
| Profit before tax | −6 | 37 872 | −706 | 2 606 | −99 | −43 |
| Tax | −0 | −0 | 25 | 25 | −0 | −0 |
| Net profit | −6 | 37 872 | −731 | 2 581 | −99 | −43 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|---|
| Total assets | 78 | 32 204 | 9 072 | 8 447 | 8 200 | 8 157 |
| Equity | 30 | 9 654 | 8 923 | 8 166 | 8 067 | 8 024 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 48 | 22 550 | 149 | 281 | 133 | 133 |
| Total debt | 48 | 22 550 | 149 | 281 | 133 | 133 |
EBITDA margin
-8315500.0%
This company
15.8%
Market median
-52629847% vs market
20142019
Equity ratio
98.4%
This company
38.2%
Market median
+158% vs market
20142019
Return on equity
-0.5%
This company
18.4%
Market median
-103% vs market
20142019
Net profit margin
-4325400.0%
This company
8.1%
Market median
-53400100% vs market
20142019
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20142019
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20142019
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2016 | — | — | |
| Chairman | 2016 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CELLVISION HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eirik Chambe-Eng | Board of Directors | 0 companies |
| Morten Christian Mo | Board of Directors | 0 companies |
| Njål Vikdal | Chairman | 0 companies |